CHEMINFORMATICS.ORG
Today's Pharma Headlines: Asklepios BioPharmaceutical launches new portfolio company Actus Therapeutics - FDA approves Pfizer’s Xeljanz and Xeljanz XR to treat active psoriatic arthritis - Drugmaker Teva to cut 14,000 jobs globally - ...